01 - NICE's response to comments on the Appraisal Consultation Document

02 - Consultee comments on the ACD – Roche - peginterferon alfa 2-a, ribavirin

03 - Consultee comments on the ACD - Merck, Sharp and Dohme - peginterferon alfa 2-b, ribavirin

04 - Consultee comments on the ACD - Royal College of Nurses

05 - Consultee comments on the ACD - Royal College of Paediatrics and Child Health

06 - Commentator comments on the ACD - Healthcare Improvement Scotland

Please be advised that the format of evaluation reports shared on the NICE website has recently changed, for ease of user navigation between individual documents contained in the report.

It is a requirement of the new (PDF portfolio) format that Adobe Reader is used to view the document. Please follow the link at the bottom of this page to download Adobe Reader if required.

If you have any feedback on the new format please contact the Project Manager for this appraisal.